(Q74816595)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

title

Long-term durability of PSA failure-free survival after radiotherapy for localized prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference

1

Torunn I Yock

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

author name string

Anthony L Zietman

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

William U Shipley

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

Harjot K Thakral

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

John J Coen

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

language of work or name

English

0 references

publication date

1 October 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Radiation Oncology Biology Physics

13 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

volume

54

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

page(s)

420-426

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

Natural history of progression after PSA elevation following radical prostatectomy

13 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

The effect of pelvic radiation therapy on serum levels of prostate specific antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

The treatment of prostate cancer by conventional radiation therapy: an analysis of long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Young patients with prostate cancer have an outcome justifying their treatment with external beam radiation

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

The durability of external beam radiation therapy for prostate cancer: can it be identified?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Radiation therapy for clinically localized prostate cancer: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Use of PSA nadir to predict subsequent biochemical outcome following external beam radiation therapy for T1-2 adenocarcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Serum prostate-specific antigen after radiation therapy for clinically localized prostate cancer: Prognostic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

External beam radiotherapy for stage T1/T2 prostate cancer: how does it stack up?

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Radical radiation therapy in the management of prostatic adenocarcinoma: the initial prostate specific antigen value as a predictor of treatment outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

External beam radiotherapy dose response characteristics of 1127 men with prostate cancer treated in the PSA era

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Dose escalation with three-dimensional conformal radiation therapy affects the outcome in prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Post-treatment PSA < or = 0.2 ng/mL defines disease freedom after radiotherapy for prostate cancer using modern techniques

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Prostate specific antigen nadir achieved by men apparently cured of prostate cancer by radiotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Dose escalation with 3D-CRT in prostate cancer: French study of dose escalation with conformal 3D radiotherapy in prostate cancer-preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

External beam radiotherapy dose response of prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

The external radiotherapy with three-dimensional conformal boost after the neoadjuvant androgen suppression for patients with locally advanced prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Androgen deprivation with radiation therapy compared with radiation therapy alone for locally advanced prostatic carcinoma: a randomized comparative trial of the Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Does androgen suppression enhance the efficacy of postoperative irradiation? A secondary analysis of RTOG 85-31. Radiation Therapy Oncology Group

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

Subset analysis of RTOG 85-31 and 86-10 indicates an advantage for long-term vs. short-term adjuvant hormones for patients with locally advanced nonmetastatic prostate cancer treated with radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2902957-7

7 January 2021

10.1016/S0360-3016(02)02957-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12243817%20AND%20SRC:MED&resulttype=core&format=json

13 November 2019

1 reference